Detalhe da pesquisa
1.
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registry.
J Gastroenterol Hepatol
; 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615197
2.
Non-linear association between long-term air pollution exposure and risk of metabolic dysfunction-associated steatotic liver disease.
Environ Health Prev Med
; 29: 7, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38346730
3.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208843
4.
Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials.
Clin Gastroenterol Hepatol
; 21(1): 90-102.e6, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074532
5.
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes.
J Formos Med Assoc
; 122(3): 202-220, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750398
6.
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial.
Clin Gastroenterol Hepatol
; 20(12): 2800-2808, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864158
7.
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Clin Gastroenterol Hepatol
; 20(5): 1151-1162.e6, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333150
8.
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
J Gastroenterol Hepatol
; 37(10): 1901-1910, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790343
9.
Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis C.
J Formos Med Assoc
; 121(11): 2265-2272, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581112
10.
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents.
J Formos Med Assoc
; 121(5): 920-929, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538552
11.
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
J Formos Med Assoc
; 121(8): 1567-1578, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123849
12.
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis.
Cancer Immunol Immunother
; 70(7): 1929-1937, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409737
13.
Persistent augmentation of central arterial stiffness following viral clearance by direct-acting antivirals in chronic hepatitis C.
J Viral Hepat
; 28(1): 159-167, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929802
14.
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Liver Int
; 41(6): 1265-1277, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655714
15.
Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
BMC Gastroenterol
; 21(1): 418, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34749663
16.
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
J Gastroenterol Hepatol
; 36(10): 2884-2892, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963615
17.
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.
J Gastroenterol Hepatol
; 36(8): 2247-2254, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624849
18.
Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan.
J Formos Med Assoc
; 120(3): 983-990, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891488
19.
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy.
J Infect Dis
; 222(8): 1345-1352, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396638
20.
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Am J Gastroenterol
; 115(8): 1226-1235, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32221162